...
首页> 外文期刊>Human Molecular Genetics >Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes
【24h】

Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes

机译:额颞痴呆危险因子TMEM106B的表达增加导致溶酶体中C9orf72依赖性改变

获取原文
获取原文并翻译 | 示例

摘要

Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is an important cause of dementia in individuals under age 65. Common variants in the TMEM106B gene were previously discovered by genome-wide association to confer genetic risk for FTLD-TDP (p = 1 x 10(-11), OR = 1.6). Furthermore, TMEM106B may act as a genetic modifier affecting age at onset and age at death in the Mendelian subgoup of FTLD-TDP due to expansions of the C9orf72 gene. Evidence suggests that TMEM106B variants increase risk for developing FTLD-TDP by increasing expression of Transmembrane Protein 106B (TMEM106B), a lysosomal protein. To further understand the functional role of TMEM106B in disease pathogenesis, we investigated the cell biological effects of increased TMEM106B expression. Here, we report that increased TMEM106B expression results in the appearance of a vacuolar phenotype in multiple cell types, including neurons. Concomitant with the development of this vacuolar phenotype, cells over-expressing TMEM106B exhibit impaired lysosomal acidification and degradative function, as well as increased cytotoxicity. We further identify a potential lysosomal sorting motif for TMEM106B and demonstrate that abrogation of sorting to lysosomes rescues TMEM106B-induced defects. Finally, we show that TMEM106B-induced defects are dependent on the presence of C9orf72, as knockdown of C9orf72 also rescues these defects. In sum, our results suggest that TMEM106B exerts its effects on FTLD-TDP disease risk through alterations in lysosomal pathways. Furthermore, TMEM106B and C9orf72 may interact in FTLD-TDP pathophysiology.
机译:TDP-43夹杂物(FTLD-TDP)的额颞叶变性是65岁以下个体痴呆的重要原因。TMEM106B基因的常见变异先前是通过全基因组关联发现的,从而赋予FTLD-TDP遗传风险(p = 1 x 10(-11),或= 1.6)。此外,由于C9orf72基因的扩增,TMEM106B可以作为遗传修饰物,影响FTLD-TDP孟德尔亚组的发病年龄和死亡年龄。有证据表明,TMEM106B变体通过增加溶酶体蛋白跨膜蛋白106B(TMEM106B)的表达来增加发展FTLD-TDP的风险。为了进一步了解TMEM106B在疾病发病机理中的功能作用,我们研究了TMEM106B表达增加的细胞生物学效应。在这里,我们报告增加的TMEM106B表达导致液泡表型出现在多种细胞类型,包括神经元。伴随这种液泡表型的发展,过表达TMEM106B的细胞表现出溶酶体酸化和降解功能受损,以及细胞毒性增加。我们进一步确定了TMEM106B的潜在溶酶体分选基序,并证明了取消对溶酶体的分选挽救了TMEM106B诱导的缺陷。最后,我们显示TMEM106B诱导的缺陷取决于C9orf72的存在,因为C9orf72的敲除也可以挽救这些缺陷。总之,我们的结果表明,TMEM106B通过改变溶酶体途径对FTLD-TDP疾病风险产生影响。此外,TMEM106B和C9orf72可能在FTLD-TDP病理生理学中相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号